Patents by Inventor Adeoye Y. Olukotun

Adeoye Y. Olukotun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
    Patent number: 6369103
    Abstract: A method is provided for preventing or reducing the risk of onset of a cardiovascular event by administering an HMG CoA reductase inhibitor such as pravastatin, to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia.
    Type: Grant
    Filed: January 18, 1994
    Date of Patent: April 9, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Bruce D. Behounek, Mark E. McGovern, Adeoye Y. Olukotun
  • Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
    Patent number: 5691375
    Abstract: A method is provided for preventing or reducing the risk of onset of a cardiovascular event by administering an HMG CoA reductase inhibitor such as pravastatin, to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: November 25, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Bruce D. Behounek, Mark E. McGovern, Adeoye Y. Olukotun
  • Method for preventing reducing or risk of onset of cerebrovascular events employing an HMG CoA reductase inhibitor
    Patent number: 5674893
    Abstract: A method is provided for preventing or reducing the risk of onset of a cardiovascular event by administering an HMG CoA reductase inhibitor such as pravastatin, to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia.
    Type: Grant
    Filed: June 26, 1996
    Date of Patent: October 7, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Bruce D. Behounek, Mark E. McGovern, Adeoye Y. Olukotun